Discovery
Moffitt wins USD 1.66 million NCI grant to target MYC-driven inflammation in myelofibrosis
Moffitt Cancer Center has received a USD 1.66 million National Cancer Institute R01 renewal to investigate a MYC-driven inflammatory pathway as a potential...
New York Genome Center aims to lower barriers to spatial multi-omics with NIH funding
New York Genome Center (NYGC) has received a USD 2.68 million NIH R01 grant from the National Human Genome Research Institute to develop a cost-accessible...
Washington Uni explores whether sleep aid suvorexant can slow Alzheimer's pathology
Washington University in St. Louis has received a USD 1.47 million National Institute on Aging R01 renewal to evaluate whether chronic treatment with the...
MSK backed by NCI to explore lethal hyperactivation of WNT, MAPK, and PI3K in colorectal cancer
Memorial Sloan-Kettering Cancer Center has received a USD 1.71 million NCI OT2 award to pursue a counterintuitive approach to colorectal cancer treatment:...
CraniUS wins NIH support to advance NeuroPASS brain drug delivery platform toward glioblastoma trial
Baltimore-based CraniUS Therapeutics has received an initial USD 1.1 million award through the NIH Blueprint MedTech Optimizer Program, with the potential...
Siren Bio advances AAV immune-gene therapy into clinical trials for recurrent glioblastoma
San Francisco-based Siren Biotechnology has received a USD 8 million CLIN2 grant from the California Institute for Regenerative Medicine (CIRM) to advance...
HSS researchers uncover hidden driver of rheumatoid arthritis beyond inflammation
Researchers at the Hospital for Special Surgery (HSS) Research Institute in New York have identified a distinct immune cell population that appears to drive...
University of Pennsylvania investigates discontinuing anti-CD20 therapy in relapsing MS
The University of Pennsylvania has received a USD 1.34 million NIH U01 award to conduct a randomized, placebo-controlled trial testing whether ocrelizumab...
BIDMC wins NIH grant to study ADAMTS13 deficiency beyond rare clotting disorder
Beth Israel Deaconess Medical Center (BIDMC) has received a USD 1.63 million NIH R01 grant from the National Heart, Lung, and Blood Institute to investigate...
Brigham and Women's investigates "affinity birth" in B cells to expand antibody repertoire plasticity
Brigham and Women's Hospital has received a USD 3 million NIH R01 grant from the National Institute of Allergy and Infectious Diseases to investigate...
Duke University launches multiscale immune systems modeling center to link molecular dynamics with population-level disease outcomes
Duke University has received a USD 4.8 million NIAID U54 award to establish a Center for Multiscale Immune Systems Modeling, reflecting sustained federal...
Vellum Biotechnology develops electrophoresis-based method to unlock nucleic acids from archived tissue samples
Palo Alto-based Vellum Biotechnology, Inc. has received a USD 1.01 million NIH SBIR R44 grant from the National Human Genome Research Institute to develop...
AECOM investigates novel protein-RNA interaction to block and lock HIV-1 latency
Albert Einstein College of Medicine has received a USD 3.2 million NIH R01 grant from the National Institute of Allergy and Infectious Diseases to...
Yale investigates immune mechanisms driving celiac disease to find new therapies and biomarkers
Yale University has received a USD 2.3 million NIAID P01 program project grant to investigate the immunopathogenesis of celiac disease, with a dual focus on...
Tulane Uni investigates CD4+ T cell immunity to improve pneumonia vaccines
Tulane University has received a USD 1.09 million NIH R35 award from the National Heart, Lung, and Blood Institute to investigate CD4+ T cell immunity in...
The AllSci Brief
Free, systematic R&D and deal news. Daily.